FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1473711000001109: Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24666501000001113 Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
24666601000001112 Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has excipient Cetyl alcohol false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Is a Co-amoxiclav 250mg/125mg tablets 21 tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Is pack of Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has AMP Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Sandoz Ltd) 21 tablet Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start